【レポートの概要(一部)】
1. Report Overview
1.1 Overview of the Osteoporosis Industry and Market 2016-2026
1.2 Why You should Read this Report
1.3 How this Study Delivers
1.4 Main Questions Answered by this Report
1.5 Who is this Investigation for?
1.6 Method of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Associated Reports
1.9 About visiongain
2. Introduction to Osteoporosis
2.1 Osteoporosis Prevalence and Incidence in 2015
2.2 Osteoporosis: The Silent Killer
2.3 Osteoblasts are Critical in Bone Healing
2.4 Classifying Osteoporosis by Types
2.5 Classifying Osteoporosis by Treatments
2.5.1 Antiresorptive Medication
2.5.2 Anabolic Medication
2.6 Osteoporosis Risk Factors
3. Global Forecast for the Osteoporosis Market 2016-2026
3.1 The Global Osteoporosis Drug Market in 2015
3.2 The Global Osteoporosis Drug Market Forecast, 2016-2026
3.3 The Global Osteoporosis Market by Main Therapeutic Class, 2016-2026
3.3.1 The Antiresorptive Drug Submarket
3.3.1.1 Antiresorptive Drug Submarket Forecast 2016-2026
3.3.2 The Anabolic Drug Submarket
3.3.2.1 Anabolic Drug Submarket Forecast 2016-2026
3.3.3 The Others Submarket
3.3.3.1 The Others Submarket Forecast 2016-2026
3.4 Drivers and Restraints for the Global Osteoporosis Market 2016-2026
4. Individual Osteoporosis Drug Revenue Forecasts 2016-2026
4.1 The Bisphosphonates Submarket
4.1.1 The Bisphosphonates Revenue Forecast, 2016-2026
4.1.2 Merck (MSD)’s Fosamax (Alendronate)
4.1.2.1 Generic Competition for Fosamax in 2016
4.1.2.2 Fosamax Market Forecast 2016-2026
4.1.3 Roche’s Bonviva/Boniva (Ibandronate)
4.1.3.1 Boniva/Bonviva Market Forecast 2016-2026
4.1.4 Sanofi’s Actonel/Atelvia (Risedronate)
4.1.4.1 Actonel/Atelvia Market Forecast 2016-2026
4.1.5 Novartis’ Reclast/Aclasta (Zoledronate)
4.1.5.1 Reclast/Aclasta (Zoledronate) in the Leading National Markets, 2016
4.1.5.2 Generic Competition for Reclast/Aclasta (Zoledronate), 2016
4.1.5.3 Reclast/Aclasta (Zoledronate) Market Forecast 2016-2026
4.1.6 Ono Pharmaceutical’s/Astellas’ Recalbon/Bonoteo (Minodronate)
4.1.6.1 Recalbon/Bonoteo Market Forecast, 2016-2026
4.2 The SERMs Submarket
4.2.1 The SERMs Revenue Forecast, 2016-2026
4.2.2 Eli Lilly’s Evista (Raloxifene)
4.2.2.1 Generic Raloxifene Slashes Evista Profits
4.2.2.2 Evista Market Forecast 2016-2026
4.2.3 Pfizer’s Duavee
4.2.3.1 Duavee Market Forecast 2016-2026
4.3 The Global RANKL Antibody Market Forecast, 2016-2026
4.3.1 Amgen’s Prolia (Denosumab)
4.3.1.1 History of Prolia (Denosumab)
4.3.1.2 Prolia (Denosumab) Market Forecast 2016-2026
4.4 The Parathyroid Hormone Submarket
4.4.1 Parathyroid Hormone Submarket Forecast 2016-2026
4.4.2 Eli Lilly’s Forteo (Teriparatide)
4.4.3 Forteo Market Forecast 2016-2026
4.4.4 Preotact/Preos Withdrawn from the Market
4.5 The Others Submarket
4.5.1 The Others Submarket Forecast 2016-2026
4.5.2 Servier’s Protelos (Strontium Ranelate) 2016-2026
4.5.3 Protelos Market Forecast 2016-2026
5. Pipeline Drugs for the Osteoporosis Market 2016-2026
5.1 Merck (MSD)’s Odanacatib (MK 0822)
5.1.1 Odanacatib Market Forecast 2016-2026
5.2 Amgen’s Romosozumab (AMG 785)
5.2.1 Romosozumab Market Forecast 2016-2026
5.3 Blosozumab (LY2541546)
5.4 Radius Health’s Abaloparatide (BA-058)
5.4.1 Abaloparatide Market Forecast 2016-2026
5.5 ZP-PTH: Parathyroid
5.6 ZT-034: Will Need More Than Biomarkers for Approval
6. National Submarkets for the Osteoporosis Market 2016-2026
6.1 The Global Osteoporosis Market by Regional Breakdown, 2015, 2020 and 2026
6.2 The Global Osteoporosis Market Forecast by Regional Breakdown, 2015, 2020 and 2026
6.3 The US Osteoporosis Drug Market, 2015
6.3.1 The US Osteoporosis Market Forecast, 2016-2026
6.3.2 The Reimbursement System of the US
6.3.3 The US Must Improve Osteoporosis Preventation Measures
6.3.4 Drivers and Restraints for the US Osteoporosis Market, 2016-2026
6.4 The EU5 Osteoporosis Osteoporosis Market Forecasts, 2016-2026
6.4.1 The German Osteoporosis Market Forecast, 2016-2026
6.4.2 The French Osteoporosis Market Forecast, 2016-2026
6.4.3 The UK Osteoporosis Drug Market Forecast, 2016-2026
6.4.4 The Italian Osteoporosis Market Forecast, 2016-2026
6.4.5 The Spanish Osteoporosis Market Forecast, 2016-2026
6.5 The Japanese Osteoporosis Drug Market, 2015
6.5.1 The Japanese Osteoporosis Market Forecast, 2016-2026
6.5.2 Recent Trends in the Japanese Osteoporosis Market
6.6 The BRIC Countries Osteoporosis Market, 2015
6.6.1 The BRIC Countries Osteoporosis Market Forecast, 2016-2026
6.6.2 The Chinese Osteoporosis Market Forecast, 2016-2026
6.6.2.1 Drivers of Growth in the Chinese Market
6.6.3 The Indian Osteoporosis Market Forecast, 2016-2026
6.6.4 The Russian Osteoporosis Market Forecast, 2016-2026
6.6.5 The Brazilian Osteoporosis Market Forecast, 2016-2026
6.7 The South Korean Osteoporosis Market, 2016-2026
6.8 The Osteoporosis Market for the Rest of the World, 2016-2026
6.9 Additional Considerations for the National Osteoporosis Markets
7. Market Leaders for the Osteoporosis Market 2016-2026
7.1 Market Leaders in 2015
7.2 Eli Lilly
7.2.1 Eli Lilly Osteoporosis Drug Sales Forecast, 2016-2026
7.3 Amgen
7.3.1 Amgen: Reacquires All Rights for Prolia from GSK
7.3.2 Amgen Osteoporosis Drug Sales Forecast, 2016-2026
7.4 UCB
7.4.1 UCB Osteoporosis Drug Sales Forecast, 2016-2026
7.5 GSK
7.6 Merck and Co. (MSD)
7.6.1 Merck (MSD) Osteoporosis Drug Sales Forecast, 2016-2026
7.7 Allergan
7.8 Sanofi
7.9 Pfizer
7.10 Novartis
7.11 Radius Health
8. Qualitative Analysis of the Osteoporosis Market
8.1 SWOT (Strengths, Weaknesses, Opportunities and Threats) Analysis of the Osteoporosis Market, 2016-2026
8.2 STEP (Social, Technological, Economic and Political) Analysis of the Osteoporosis Market, 2016-2026
9. Research Interviews
9.1 Interview with Amy Porter, CEO and Executive Director of the National Osteoporosis Foundation (NOF), US and Clare Gill, Senior Director, Marketing, Consumer and Corporate Outreach at the NOF
9.1.1 On the Problem of Osteoporosis in Today’s Society
9.1.2 On the Work of the National Osteoporosis Foundation
9.1.3 On Drug Treatments and the Prevention of Osteoporosis
9.2 Interview with Paul Mitchell, Founder of Synthesis Medical Limited
9.2.1 On the Work of Synthesis Medical
9.2.2 On the Burden of Osteoporosis to Society
9.2.3 On Education and Policy for Osteoporosis
9.2.4 On Primary and Secondary Fractures
9.2.5 On Drug Treatments and Innovation for Osteoporosis
9.3 Interview with Cathy Yi, Orthopaedic Physical Therapy Clinical Specialist, Pursuit Physical Therapy
9.3.1 On the Therapy used at Pursuit Physical Therapy
9.3.2 On Primary and Secondary Fractures
9.3.3 On Education and Innovation for Osteoporosis
10. Conclusions
10.1 The Global Osteoporosis Market and Submarkets in 2015
10.2 The Global Osteoporosis Market and Submarkets until 2026
10.3 The National Markets for Osteoporosis in 2015
10.4 The National Markets for Osteoporosis until 2026
10.5 Leading Companies in the Osteoporosis Market
10.6 Drivers for the Osteoporosis Market
10.7 Challenges to Overcome for the Future Osteoporosis Drug Market
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain Report Evaluation Form
【レポート販売概要】
■ タイトル:骨粗鬆症治療薬の世界市場2016-2026■ 英文:Osteoporosis Global Market 2016-2026
■ 発行日:2016年4月
■ 調査会社:visiongain
■ 商品コード:VGAIN6041540
■ 調査対象地域:グローバル
- 北米の手術室用装置市場見通し(~2021)North America Operating Room Equipment Market Outlook to 2021 Summary GlobalData’s new report, "North America Operating Room Equipment Market Outlook to 2021", provides key market data on the North America Operating Room Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Operating Room Tables, O …
- 電力産業向け工業用バルブの世界市場2018-2022About this market Valve diagnosis is gaining prominence in the industrial valves market in power industry. Valves cover almost all aspects of a power plant, offering great control to operators over plant operations. Technavio’s analysts have predicted that the industrial valves market in power industry will register a CAGR of close to 4% by 2022. Market Overview Growing demand for power Power dema …
- 世界のペットケア市場動向(2014-2018)About Pet Care Products Pet care products are developed specifically for household pets and include food, healthcare products, grooming products, hygiene products, and accessories. Pet food is specially formulated from either plant or animal extracts to meet the nutritional needs of domesticated animals such as cats, dogs, birds, and fish according to the type and age of the animal being fed. Tech …
- ヘルスケア解析の世界市場分析:タイプ別(ソフトウェア、ハードウェア、サービス)、コンポーネント別(記述的、予測的、処方的)、送達モード別(オンプレミス、Webベース、クラウドベース)、用途別(臨床、財務、運営・管理)、エンドユーザー別(医療保険者、医療提供者)、セグメント予測The global healthcare analytics (HA) market is expected to reach USD 42.8 billion by 2024, according to a new report by Grand View Research, Inc. Efforts to reduce the spiraling healthcare costs is facilitating the usage of the healthcare analytics. Additionally, the benefits of HA include the improvement of patient access to customized care, the furthering of transparent operations to enable bett …
- フレキシブル機器向けロールツーロールプリンティングの世界市場:材料、装置、印刷技術、用途、エンドユーザー、地域別分析The global roll-to-roll printing market for flexible devices is expected to grow from USD 16.31 Billion in 2015 to USD 35.79 Billion by 2022 at a CAGR of 11.04% between 2016 and 2022. The market for flexible devices is expected to grow substantially due to factors such as the advantages of using flexible devices in the electronics industry, high speed fabrication using roll-to-roll printing, and t …
- 飲料におけるカルシウム強化:成分トレンドと市場インサイトSummary Review of Calcium fortification ingredients typically used in fortification of Foods and Beverages. Specific focus on Calcium types and ingredient industry key players. The need and relevance for various consumer age groups as well as demographic differences in relation to bone health. The report investigates the use of calcium fortifiers in Non-Dairy Alternatives and Soft Drinks as well a …
- 肺活量計の世界市場予測Spirometer Market, by Product (Hand-held, Table-top, Desktop (PC)), by Technology (Volume Measurement, Flow Measurement, Peak Flow Meters (PFM)), by End User, by Application, by Geography – Global Forecast to 2020 A spirometer is an instrument used to measure the air inhaled into and exhaled out of the lungs. It provides a simple of way of measuring lung volume and capacity, and is used in pulmona …
- 芝生及び観賞植物用バイオスティミュラント(生物刺激剤)の世界市場The global agricultural bio stimulants in turf & ornamentals market is estimated to grow at a CAGR of 14.5% from 2014 to 2019. Countries, such as the U.S., Spain, and Italy held substantial share in the agricultural bio stimulants in turf & ornamentals market in 2013. Furthermore, the agricultural bio stimulants in turf & ornamentals market in Latin America is expected to grow at a CAGR of 15.6% f …
- ターボコンプレッサーの世界市場:遠心式ターボコンプレッサー、軸流式ターボコンプレッサーThis report estimates the turbocompressor market size in terms of $million. The market has been broken down into component regions and further split into countries. Turbocompressors are used in all aspects of natural gas development. In the production stage, compressors are used along with gathering equipment systems at the wellhead to compress gas for fluid removal and pressure equalization. Howe …
- L-Quebrachitolの世界市場L-Quebrachitol (CAS 642-38-6) Market Research Report 2013 presents comprehensive data on l-quebrachitol markets globally and regionally (Europe, Asia, North America etc.) The L-Quebrachitol (CAS 642-38-6) Market Research Report 2013 includes l-quebrachitol description, covers its application areas and related patterns. It overviews l-quebrachitol market, names l-quebrachitol producers and indicate …
- 血管造影装置の世界市場:技術別(X線、MRA、CT)、製品別(血管造影システム、造影剤)、処置別、用途別、セグメント予測The global angiography equipment market size is expected to reach USD 16.2 billion by 2026, according to a new report by Grand View Research, Inc. The market is expected to witness an exponential CAGR of 6.5% over the forecast period due to growing geriatric population, increasing prevalence of Cardiovascular Diseases (CVDs) with associated risk factors, technological advancements, and investments …
- 市場統合シナリオ:Orthopedics Market Consolidation: Who will not survive?This report provides a worldwide strategic overview of the orthopedics market, including: In addition, the report presents a concise review of the major U.S. and international trends with potentially significant impact on the orthopedics market during the next five years, including industry consolidation, market globalization, environmental regulations, etc. The analysis of major market segments, …
- 世界の車載BYOD(Bring Your Own Device)市場:スマートフォン、タブレット、組込みコネクテッドカーシステムThe Automotive BYOD market is set for exponential growth over the next few years. In 2014, the technology is poised to see substantial uptake due to the growing number of connected devices, and the growing success and uptake of connected car technologies recently. Consumer devices such as smartphones, tablets, wearable gadgets and eReaders are currently enjoying high adoption rates across the glob …
- 同期調相機の世界市場予測(~2021年)“The synchronous condensers market is expected to reach USD 572.9 million by 2021, at a CAGR of 2.1% from 2016 to 2021”The synchronous condensers market is projected to reach USD 572.9 million by 2021, growing at a CAGR of 2.1% from 2016 to 2021. The increasing electrical power consumption and rising need to maximize transmission capacity are becoming increasingly important. Along with this, growi …
- Teleflex Incorporated:市場シェア分析Teleflex Incorporated Market Share Analysis Summary GlobalData’s new report, “Teleflex Incorporated Market Share Analysis” provides in-depth information on Teleflex Incorporated’s market position in the different medical equipment markets it operates in. The report provides Teleflex Incorporated market share information in seven key market categories – Cardiac Assist Devices, Incontinence Devices, …